(Q49164031)

15 June 2018

title

Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11. (English)

1 reference

15 June 2018

1 reference

Y Sasaki

1

1 reference

15 June 2018

Y Yoshida

2

1 reference

15 June 2018

K Sudoh

3

1 reference

15 June 2018

H Hakusui

4

1 reference

15 June 2018

H Fujii

5

1 reference

15 June 2018

T Ohtsu

6

1 reference

15 June 2018

H Wakita

7

1 reference

15 June 2018

T Igarashi

8

1 reference

15 June 2018

K Itoh

9

1 reference

15 June 2018

publication date

1 January 1995

1 reference

15 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

15 June 2018

volume

86

1 reference

15 June 2018

issue

1

1 reference

15 June 2018

page(s)

111-116

1 reference

15 June 2018

The current status of camptothecin analogues as antitumor agents

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

14 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1995.TB02995.X

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920577

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7737902

12 December 2020

inferred from PubMed ID database lookup

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7737902

12 December 2020

inferred from PubMed ID database lookup

Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7737902

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1349-7006.1995.TB02995.X

1 reference

15 June 2018

PMC publication ID

5920577

1 reference

15 June 2018

PubMed publication ID

7737902

1 reference

15 June 2018